Expression of Apoptosis-related Proteins and of mRNA for dopaminergic receptors in peripheral blood mononuclear cells from patients with Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 1, 2009, Pages 88-90

  Cosentino, Marco ^a,c   Colombo, Cristina ^a   Mauri, Marco ^b   Ferrari, Marco ^a   Corbetta, Simona ^b   Marino, Franca ^a   Bono, Giorgio ^a   Lecchini, Sergio ^a  

^a Section of Experimental and Clinical Pharmacology   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Department of Clinical Medicine ^*  (Italy)

Author keywords

Alzheimer disease; Apoptosis related proteins; Dopamine receptors; Peripheral blood mononuclear cells

Indexed keywords

CASPASE 3; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, DOPAMINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 62949140063     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e318184807d     Document Type: Article

References (17)

1. Shaw LM, Korecka M, Clark CM, et al. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov. 2007;6:295-303.
2. Bartha E, Szelényi J, Szilágyi K, et al. Altered lymphocyte acetylcholinesterase activity in patients with senile dementia. Neurosci Lett. 1987;79:190-194.
3. Rabey JM, Shenkman L, Gilad GM. Cholinergic muscarinic binding by human lymphocytes: changes with aging, antagonist treatment, and senile dementia of the Alzheimer type. Ann Neurol. 1986;20:628-631.
4. Garlind A, Johnston JA, Algotsson A, et al. Decreased beta-adrenoceptor-stimulated adenylyl cyclase activity in lymphocytes from Alzheimer's disease patients. Neurosci Lett. 1997; 226:37-40.
5. Mecocci P, Polidori MC, Cherubini A, et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol. 2002;59:794-798.
6. Sulger J, Dumais-Huber C, Zerfass R, et al. The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia. Biol Psych. 1999;45: 737-742.
7. Culmsee C, Landshamer S. Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. Curr Alzheimer Res. 2006;3: 269-283.
8. Tacconi S, Perri R, Balestrieri E, et al. Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease. Exp Neurol. 2004;190: 254-262.
9. Blandini F, Sinforiani E, Paechetti C, et al. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurol. 2006;66:529-534.
10. Kumar U, Patel SC. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain. Brain Res. 2007; 1131:187-196.
11. Barbanti P, Fabbrini G, Ricci A, et al. Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease. Mechan Age Develop. 2000;120:65-75.
12. Ferrari M, Termine C, Franciotta D, et al. Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients. J Psychiatr Res. 2008 [Epub ahead of print, doi:10.1016/j.jpsychires. 2008.01.014].
13. + T and natural killer cells in Alzheimer's disease. Pharmacopsychiatry. 2006;39:220-228.
14. + regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood. 2007;109:632-642.
15. Reale M, Iarlori C, Gambi F, et al. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. Neuropharmacology. 2006;50:606-613.
16. Ilani T, Strous RD, Fuchs S. Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J. 2004;18:1600-1602.
17. Goncharova LB, Tarakanov AO. Molecular networks of brain and immunity. Brain Res Rev. 2007;55:155-166.